SEC Form D private-offering filing

TearSolutions, Inc.

A new SEC Form D private-offering notice from Charlottesville, VA, a $517,000 filer-stated offering target in Biotech. The source filing is one click away.

TearSolutions, Inc. site↗ Verified via SEC Form D

TearSolutions develops Lacripep, a novel peptide therapy for ocular surface disease including dry eye and Sjogren's syndrome related dry eye.

Filed 2025-11-10Filed to raise $517,000First money in 2025-10-29Raised so far $517,000HQ (as filed) Charlottesville, VASector Biotech ✓Stage (inferred) Pre-seedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified tearsolutions.com↗Named in the filing 9 executives & directors
Open this row on the live feed →More new filings in Virginia →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.